Cipla Ltd.

Cipla’s 100% subsidiary - Cipla Europe NV has entered into a commercial collaboration with BioQuiddity Inc., covering the territory of the European Union and certain other European countries, for BioQuiddity’s OneDose ReadyfusOR in regional anesthetic applications for post-surgical pain management.

Cipla intends to launch the CE Marked OneDose ReadyfusOR pre-filled with Ropivacaine under its own label into the German market late this year. The ready-to-use infusion systems are non-electric, ambulatory, and should enable seamless transition between sites of care.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries.